On August 29, the production workshop of Heilongjiang Unicornshell Pharmaceutical Technology Co., Ltd., a wholly‑owned subsidiary of Shanghai Unicornshell Pharmaceutical Technology Co., Ltd., was successfully topped out, marking a new stage in the project's construction. This is the first topped‑out project under construction in Unicornshell's Northeast China industrial cluster layout, carrying significant strategic importance. The first phase is expected to be completed and put into operation by the end of 2025.

01 Heilongjiang Project: A Key Part of the Strategic Layout

The Heilongjiang Unicornshell project is located in Keshan County, Qiqihar City. It is an important component of Unicornshell's Northeast China industrial cluster layout and is scheduled to begin production by the end of 2025. With the topping out of the production workshop, the construction of the production base is advancing as planned, which will provide strong support for Unicornshell's future capacity expansion and market layout.

02 Unicornshell Moves Toward a New Chapter of Industrial Upgrading

Innovation‑Driven and Industrial Upgrading
Headquartered in Shanghai, Unicornshell focuses on the R&D, production, and sales of HPMC pharmaceutical excipients and innovative traditional Chinese medicine (TCM) formulations, striving to become a leader in the intelligent manufacturing of HPMC capsules. Through an industrial cluster model, the company promotes the deep integration of intelligent manufacturing and new materials, empowering the upgrading of the traditional pharmaceutical industry and supporting the development of green pharmaceuticals and TCM modernization.

Steady Progress in Modern Construction
The new fully automated GMP production workshop at the Heilongjiang base is being constructed in an orderly manner as planned. The topping out of the production workshop marks a new phase in the project's construction. The steady progress of the base construction provides a solid foundation for subsequent equipment installation, commissioning, and production preparation. The first phase is expected to be completed and put into operation by the end of this year.

03 Future Outlook: Green and Intelligent Development

With the successful topping out of the production workshop, Unicornshell will continue to deepen its strategy of "green, safe, and intelligent", promote the upgrading of the green pharmaceutical industry, and contribute to global health. Driven by innovation, the company will further advance its industrial layout and continue to lead the development of the green pharmaceutical industry.